APA (7th ed.) Citation

L, X., K, S., J, M., R, P., M, K., E, R., . . . M, H. (2021). Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(15), 4338. https://doi.org/10.1158/1078-0432.CCR-20-2357

Chicago Style (17th ed.) Citation

L, Xiao, et al. "Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27, no. 15 (2021): 4338. https://doi.org/10.1158/1078-0432.CCR-20-2357.

MLA (9th ed.) Citation

L, Xiao, et al. "Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 15, 2021, p. 4338, https://doi.org/10.1158/1078-0432.CCR-20-2357.